Members
Education: Cand. Polit., Economics.
Other directorships: Chairman of Tandlægen.dk - Holding A/S and Qufora A/S. Ordinary Board member in Sonion A/S, Colony ApS and Technical University of Denmark (DTU) POC Board. Former senior positions at Demant A/S, including President Demant Inc.
Independent of company and major shareholders.
Education: B.Sc. Medicine, M.Sc. Bioengineering, B.Sc. Mathematics, Ph.D. Neurophysiology, Ph.D. Engineering (hc), Graduate from Swedish armed forces language school.
Other directorships: General partner Fåhraeus Startup and Growth I & II, Chairman of the Board EQL Pharma AB (publ). Board member Ossdsign AB (publ), Checkin AB (publ), Airsonett AB (publ), Bionamic AB and Flatfrog Laboratories AB. Founder of EQL Pharma AB and Flatfrog Laboratories AB among others.
Independent of company. Dependent on major shareholders.
Education: B.Sc. Business Administration, University Diploma in Journalism.
Other directorships: Board member Exsitec Holding AB (publ.) and Broviken Gruppen AB. Former experiences include CFO at Addnode Group, Acando and Protect Data, Board member Metria, and Authorized Public Accountant at PwC.
Independent of company and major shareholders.
Education: M.Sc. Advanced Analytical Chemistry, Ph.D. Analytical Chemistry.
Other directorships: VP EMEA Sales, Microscopy and Imaging Solutions, Evident Scientific. Previous experiences include: CCO Visiopharm A/S, Global Sales Director Andor Technology and many years in global product management and sales roles at PerkinElmer.
Independent of company and major shareholders.
Education: Biological Laboratory Science.
Other directorships: Senior Healthcare Advisor. Former CEO of The Binding Site Group Ltd (part of Thermo Fisher Scientific). Past experiences include CEO of Hemostasis, Hematology, and Specialty Diagnostics at Siemens Healthineers and Division President of Immuno Diagnostic & Clinical Diagnostic Division at Thermo Fisher Scientific.
Independent of company and major shareholders.
Education: MSc. Industrial Economics and Management, and BSc. Mechanical Engineering
Other directorships: Chief Investment Officer at AB Grenspecialisten. Past experiences include Credit Research at Danske Bank Markets and Nordea Markets. Ordinary Board Member in Exsitex, Trianon, Lime Technologies and Boule Diagnostics.
Independent of company. Dependent on major shareholders.
Education: Ph.D. Applied Mathematics.
Employed since 2000. Current position, Product Manager.
Board member appointed by the unions since 2022.
Education: M.Sc. Engineering Physics.
Employed since 2005. Current position, Engineering Manager.
Board member appointed by the unions since 2020.
Education: High school Mechanical Engineer.
Employed since 2006. Current position: Strategic Sourcing Manager.
Board member appointed by the unions since 2025.
Nomination Committee
Ahead of the Annual General Meeting in 2025, the Nomination Committee consists of: Christer Fåhraeus (appointed by Christer Fåhraeus with Companies), Nicklas Hansen (appointed by William Demant Invest A/S), Anette Andersson (appointed by SEB Investment funds), and Joel Eklund (appointed by Grenlunden CEVI AB).
Shareholders wishing to submit proposals to the Nomination Committee can email ir@cellavision.com or ordinary mail to: The Nomination Committee, CellaVision AB, Mobilvägen 12, 223 62 Lund.
Audit & Remuneration Committees
Audit Committee
The CellaVision Audit Committee was appointed within the Board in 2011. The committee comprises Mikael Worning, and Ann-Charlotte Jarleryd (Chairman).
Remuneration Committee
The CellaVision Remuneration Committee was appointed within the Board in 2011. The committee comprises Christer Fåhraeus, Stefan Wolf and Mikael Worning (Chairman).